Guardant Health, Inc. Forecast, price target & analysts
Guardant Health, Inc. Target price 2025 - Analyst rating & recommendation
Guardant Health, Inc. Classifications & Recommendation:
Guardant Health, Inc. Price Target
| Target Price | $71.40 |
| Price | $94.37 |
| Deviation |
24.34%
register free of charge
|
| Number of Estimates | 27 |
|
27 Analysts have issued a price target Guardant Health, Inc. 2026 .
The average Guardant Health, Inc. target price is $71.40.
This is
24.34%
register free of charge
$94.50
0.14%
register free of charge
$35.35
62.54%
register free of charge
|
|
| A rating was issued by 33 analysts: 30 Analysts recommend Guardant Health, Inc. to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Guardant Health, Inc. stock has an average upside potential 2026 of
24.34%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 739.02 | 989.92 |
| 31.04% | 33.95% | |
| EBITDA Margin | -54.29% | -22.91% |
| 41.33% | 57.80% | |
| Net Margin | -59.05% | -40.33% |
| 30.55% | 31.70% |
28 Analysts have issued a sales forecast Guardant Health, Inc. 2025 . The average Guardant Health, Inc. sales estimate is
This results in the following potential growth metrics:
25 Analysts have issued an Guardant Health, Inc. EBITDA forecast 2025. The average Guardant Health, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
28 Guardant Health, Inc. Analysts have issued a net profit forecast 2025. The average Guardant Health, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.56 | -3.19 |
| 16.82% | 10.39% | |
| P/E | negative | |
| EV/Sales | 12.87 |
28 Analysts have issued a Guardant Health, Inc. forecast for earnings per share. The average Guardant Health, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Guardant Health, Inc....
Current Guardant Health, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Oct 22 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BTIG:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Oct 22 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
